Chimerix (NASDAQ: CMRX) reported Q4 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $814 thousand versus the consensus estimate of $80 thousand.

For earnings history and earnings-related data on Chimerix (CMRX) click here.